nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—Pollakiuria—Epirubicin—bone cancer	0.00159	0.00159	CcSEcCtD
Varenicline—Photosensitivity reaction—Epirubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Varenicline—Feeling abnormal—Cisplatin—bone cancer	0.00157	0.00157	CcSEcCtD
Varenicline—Weight increased—Epirubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Varenicline—Hyperglycaemia—Epirubicin—bone cancer	0.00156	0.00156	CcSEcCtD
Varenicline—Angina pectoris—Doxorubicin—bone cancer	0.00156	0.00156	CcSEcCtD
Varenicline—Hepatobiliary disease—Methotrexate—bone cancer	0.00155	0.00155	CcSEcCtD
Varenicline—Epistaxis—Methotrexate—bone cancer	0.00155	0.00155	CcSEcCtD
Varenicline—Infestation NOS—Epirubicin—bone cancer	0.00154	0.00154	CcSEcCtD
Varenicline—Infestation—Epirubicin—bone cancer	0.00154	0.00154	CcSEcCtD
Varenicline—Bronchitis—Doxorubicin—bone cancer	0.00154	0.00154	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00153	0.00153	CcSEcCtD
Varenicline—Body temperature increased—Cisplatin—bone cancer	0.00151	0.00151	CcSEcCtD
Varenicline—Stomatitis—Epirubicin—bone cancer	0.0015	0.0015	CcSEcCtD
Varenicline—Conjunctivitis—Epirubicin—bone cancer	0.0015	0.0015	CcSEcCtD
Varenicline—Pollakiuria—Doxorubicin—bone cancer	0.00147	0.00147	CcSEcCtD
Varenicline—Urinary tract disorder—Methotrexate—bone cancer	0.00146	0.00146	CcSEcCtD
Varenicline—Photosensitivity reaction—Doxorubicin—bone cancer	0.00146	0.00146	CcSEcCtD
Varenicline—Hepatobiliary disease—Epirubicin—bone cancer	0.00145	0.00145	CcSEcCtD
Varenicline—Weight increased—Doxorubicin—bone cancer	0.00145	0.00145	CcSEcCtD
Varenicline—Epistaxis—Epirubicin—bone cancer	0.00145	0.00145	CcSEcCtD
Varenicline—Urethral disorder—Methotrexate—bone cancer	0.00145	0.00145	CcSEcCtD
Varenicline—Sinusitis—Epirubicin—bone cancer	0.00144	0.00144	CcSEcCtD
Varenicline—Hyperglycaemia—Doxorubicin—bone cancer	0.00144	0.00144	CcSEcCtD
Varenicline—Infestation NOS—Doxorubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Varenicline—Infestation—Doxorubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Varenicline—Visual impairment—Methotrexate—bone cancer	0.00142	0.00142	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Varenicline—Hypersensitivity—Cisplatin—bone cancer	0.00141	0.00141	CcSEcCtD
Varenicline—Bradycardia—Epirubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Varenicline—Erythema multiforme—Methotrexate—bone cancer	0.0014	0.0014	CcSEcCtD
Varenicline—Stomatitis—Doxorubicin—bone cancer	0.00139	0.00139	CcSEcCtD
Varenicline—Conjunctivitis—Doxorubicin—bone cancer	0.00138	0.00138	CcSEcCtD
Varenicline—Eye disorder—Methotrexate—bone cancer	0.00138	0.00138	CcSEcCtD
Varenicline—Tinnitus—Methotrexate—bone cancer	0.00138	0.00138	CcSEcCtD
Varenicline—Hypoaesthesia—Epirubicin—bone cancer	0.00137	0.00137	CcSEcCtD
Varenicline—Asthenia—Cisplatin—bone cancer	0.00137	0.00137	CcSEcCtD
Varenicline—Cardiac disorder—Methotrexate—bone cancer	0.00137	0.00137	CcSEcCtD
Varenicline—Urinary tract disorder—Epirubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Varenicline—Oedema peripheral—Epirubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Varenicline—Connective tissue disorder—Epirubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Varenicline—Urethral disorder—Epirubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Varenicline—Hepatobiliary disease—Doxorubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Varenicline—Epistaxis—Doxorubicin—bone cancer	0.00134	0.00134	CcSEcCtD
Varenicline—Angiopathy—Methotrexate—bone cancer	0.00134	0.00134	CcSEcCtD
Varenicline—Sinusitis—Doxorubicin—bone cancer	0.00134	0.00134	CcSEcCtD
Varenicline—Immune system disorder—Methotrexate—bone cancer	0.00133	0.00133	CcSEcCtD
Varenicline—Visual impairment—Epirubicin—bone cancer	0.00133	0.00133	CcSEcCtD
Varenicline—Mediastinal disorder—Methotrexate—bone cancer	0.00133	0.00133	CcSEcCtD
Varenicline—Chills—Methotrexate—bone cancer	0.00132	0.00132	CcSEcCtD
Varenicline—Diarrhoea—Cisplatin—bone cancer	0.00131	0.00131	CcSEcCtD
Varenicline—Erythema multiforme—Epirubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Varenicline—Bradycardia—Doxorubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Varenicline—Mental disorder—Methotrexate—bone cancer	0.00129	0.00129	CcSEcCtD
Varenicline—Eye disorder—Epirubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Varenicline—Tinnitus—Epirubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Varenicline—Malnutrition—Methotrexate—bone cancer	0.00128	0.00128	CcSEcCtD
Varenicline—Erythema—Methotrexate—bone cancer	0.00128	0.00128	CcSEcCtD
Varenicline—Cardiac disorder—Epirubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Varenicline—Hypoaesthesia—Doxorubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Varenicline—Urinary tract disorder—Doxorubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Varenicline—Oedema peripheral—Doxorubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Varenicline—Dysgeusia—Methotrexate—bone cancer	0.00126	0.00126	CcSEcCtD
Varenicline—Connective tissue disorder—Doxorubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Varenicline—Angiopathy—Epirubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Varenicline—Urethral disorder—Doxorubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Varenicline—Immune system disorder—Epirubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Varenicline—Mediastinal disorder—Epirubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Varenicline—Back pain—Methotrexate—bone cancer	0.00124	0.00124	CcSEcCtD
Varenicline—Chills—Epirubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Varenicline—Arrhythmia—Epirubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Varenicline—Visual impairment—Doxorubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Varenicline—Vomiting—Cisplatin—bone cancer	0.00121	0.00121	CcSEcCtD
Varenicline—Vision blurred—Methotrexate—bone cancer	0.00121	0.00121	CcSEcCtD
Varenicline—Mental disorder—Epirubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Varenicline—Erythema multiforme—Doxorubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Varenicline—Rash—Cisplatin—bone cancer	0.0012	0.0012	CcSEcCtD
Varenicline—Dermatitis—Cisplatin—bone cancer	0.0012	0.0012	CcSEcCtD
Varenicline—Malnutrition—Epirubicin—bone cancer	0.0012	0.0012	CcSEcCtD
Varenicline—Erythema—Epirubicin—bone cancer	0.0012	0.0012	CcSEcCtD
Varenicline—Eye disorder—Doxorubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Varenicline—Ill-defined disorder—Methotrexate—bone cancer	0.00119	0.00119	CcSEcCtD
Varenicline—Tinnitus—Doxorubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Varenicline—Anaemia—Methotrexate—bone cancer	0.00119	0.00119	CcSEcCtD
Varenicline—Cardiac disorder—Doxorubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Varenicline—Flatulence—Epirubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Varenicline—Dysgeusia—Epirubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Varenicline—Back pain—Epirubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Varenicline—Angiopathy—Doxorubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Varenicline—Malaise—Methotrexate—bone cancer	0.00116	0.00116	CcSEcCtD
Varenicline—Muscle spasms—Epirubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Varenicline—Immune system disorder—Doxorubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Varenicline—Vertigo—Methotrexate—bone cancer	0.00115	0.00115	CcSEcCtD
Varenicline—Mediastinal disorder—Doxorubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Varenicline—Chills—Doxorubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Varenicline—Arrhythmia—Doxorubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Varenicline—Nausea—Cisplatin—bone cancer	0.00113	0.00113	CcSEcCtD
Varenicline—Vision blurred—Epirubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Varenicline—Cough—Methotrexate—bone cancer	0.00112	0.00112	CcSEcCtD
Varenicline—Mental disorder—Doxorubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Varenicline—Ill-defined disorder—Epirubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Varenicline—Convulsion—Methotrexate—bone cancer	0.00111	0.00111	CcSEcCtD
Varenicline—Erythema—Doxorubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Varenicline—Malnutrition—Doxorubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Varenicline—Anaemia—Epirubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Varenicline—Agitation—Epirubicin—bone cancer	0.0011	0.0011	CcSEcCtD
Varenicline—Flatulence—Doxorubicin—bone cancer	0.0011	0.0011	CcSEcCtD
Varenicline—Chest pain—Methotrexate—bone cancer	0.00109	0.00109	CcSEcCtD
Varenicline—Arthralgia—Methotrexate—bone cancer	0.00109	0.00109	CcSEcCtD
Varenicline—Myalgia—Methotrexate—bone cancer	0.00109	0.00109	CcSEcCtD
Varenicline—Dysgeusia—Doxorubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00109	0.00109	CcSEcCtD
Varenicline—Malaise—Epirubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Varenicline—Discomfort—Methotrexate—bone cancer	0.00108	0.00108	CcSEcCtD
Varenicline—Vertigo—Epirubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Varenicline—Syncope—Epirubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Varenicline—Back pain—Doxorubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Varenicline—Muscle spasms—Doxorubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Varenicline—Palpitations—Epirubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Varenicline—Loss of consciousness—Epirubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Varenicline—Cough—Epirubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Varenicline—Vision blurred—Doxorubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Varenicline—Convulsion—Epirubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Varenicline—Infection—Methotrexate—bone cancer	0.00104	0.00104	CcSEcCtD
Varenicline—Hypertension—Epirubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Varenicline—Ill-defined disorder—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Varenicline—Nervous system disorder—Methotrexate—bone cancer	0.00103	0.00103	CcSEcCtD
Varenicline—Anaemia—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Varenicline—Thrombocytopenia—Methotrexate—bone cancer	0.00103	0.00103	CcSEcCtD
Varenicline—Myalgia—Epirubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Varenicline—Arthralgia—Epirubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Varenicline—Chest pain—Epirubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Varenicline—Agitation—Doxorubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Varenicline—Anxiety—Epirubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Varenicline—Skin disorder—Methotrexate—bone cancer	0.00102	0.00102	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Varenicline—Hyperhidrosis—Methotrexate—bone cancer	0.00101	0.00101	CcSEcCtD
Varenicline—Discomfort—Epirubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Varenicline—Malaise—Doxorubicin—bone cancer	0.001	0.001	CcSEcCtD
Varenicline—Dry mouth—Epirubicin—bone cancer	0.001	0.001	CcSEcCtD
Varenicline—Vertigo—Doxorubicin—bone cancer	0.000999	0.000999	CcSEcCtD
Varenicline—Anorexia—Methotrexate—bone cancer	0.000999	0.000999	CcSEcCtD
Varenicline—Syncope—Doxorubicin—bone cancer	0.000998	0.000998	CcSEcCtD
Varenicline—Palpitations—Doxorubicin—bone cancer	0.000983	0.000983	CcSEcCtD
Varenicline—Oedema—Epirubicin—bone cancer	0.000981	0.000981	CcSEcCtD
Varenicline—Hypotension—Methotrexate—bone cancer	0.00098	0.00098	CcSEcCtD
Varenicline—Loss of consciousness—Doxorubicin—bone cancer	0.000978	0.000978	CcSEcCtD
Varenicline—Infection—Epirubicin—bone cancer	0.000975	0.000975	CcSEcCtD
Varenicline—Cough—Doxorubicin—bone cancer	0.000971	0.000971	CcSEcCtD
Varenicline—Shock—Epirubicin—bone cancer	0.000965	0.000965	CcSEcCtD
Varenicline—Convulsion—Doxorubicin—bone cancer	0.000964	0.000964	CcSEcCtD
Varenicline—Nervous system disorder—Epirubicin—bone cancer	0.000962	0.000962	CcSEcCtD
Varenicline—Thrombocytopenia—Epirubicin—bone cancer	0.000961	0.000961	CcSEcCtD
Varenicline—Hypertension—Doxorubicin—bone cancer	0.00096	0.00096	CcSEcCtD
Varenicline—Tachycardia—Epirubicin—bone cancer	0.000958	0.000958	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000955	0.000955	CcSEcCtD
Varenicline—Skin disorder—Epirubicin—bone cancer	0.000953	0.000953	CcSEcCtD
Varenicline—Hyperhidrosis—Epirubicin—bone cancer	0.000949	0.000949	CcSEcCtD
Varenicline—Insomnia—Methotrexate—bone cancer	0.000948	0.000948	CcSEcCtD
Varenicline—Chest pain—Doxorubicin—bone cancer	0.000947	0.000947	CcSEcCtD
Varenicline—Arthralgia—Doxorubicin—bone cancer	0.000947	0.000947	CcSEcCtD
Varenicline—Myalgia—Doxorubicin—bone cancer	0.000947	0.000947	CcSEcCtD
Varenicline—Anxiety—Doxorubicin—bone cancer	0.000944	0.000944	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00094	0.00094	CcSEcCtD
Varenicline—Discomfort—Doxorubicin—bone cancer	0.000936	0.000936	CcSEcCtD
Varenicline—Anorexia—Epirubicin—bone cancer	0.000935	0.000935	CcSEcCtD
Varenicline—Dyspnoea—Methotrexate—bone cancer	0.000935	0.000935	CcSEcCtD
Varenicline—Somnolence—Methotrexate—bone cancer	0.000932	0.000932	CcSEcCtD
Varenicline—Dry mouth—Doxorubicin—bone cancer	0.000926	0.000926	CcSEcCtD
Varenicline—Dyspepsia—Methotrexate—bone cancer	0.000923	0.000923	CcSEcCtD
Varenicline—Hypotension—Epirubicin—bone cancer	0.000917	0.000917	CcSEcCtD
Varenicline—Decreased appetite—Methotrexate—bone cancer	0.000911	0.000911	CcSEcCtD
Varenicline—Oedema—Doxorubicin—bone cancer	0.000908	0.000908	CcSEcCtD
Varenicline—Gastrointestinal disorder—Methotrexate—bone cancer	0.000905	0.000905	CcSEcCtD
Varenicline—Fatigue—Methotrexate—bone cancer	0.000904	0.000904	CcSEcCtD
Varenicline—Infection—Doxorubicin—bone cancer	0.000902	0.000902	CcSEcCtD
Varenicline—Pain—Methotrexate—bone cancer	0.000897	0.000897	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000894	0.000894	CcSEcCtD
Varenicline—Shock—Doxorubicin—bone cancer	0.000893	0.000893	CcSEcCtD
Varenicline—Nervous system disorder—Doxorubicin—bone cancer	0.00089	0.00089	CcSEcCtD
Varenicline—Thrombocytopenia—Doxorubicin—bone cancer	0.000889	0.000889	CcSEcCtD
Varenicline—Insomnia—Epirubicin—bone cancer	0.000887	0.000887	CcSEcCtD
Varenicline—Tachycardia—Doxorubicin—bone cancer	0.000886	0.000886	CcSEcCtD
Varenicline—Skin disorder—Doxorubicin—bone cancer	0.000882	0.000882	CcSEcCtD
Varenicline—Hyperhidrosis—Doxorubicin—bone cancer	0.000878	0.000878	CcSEcCtD
Varenicline—Dyspnoea—Epirubicin—bone cancer	0.000875	0.000875	CcSEcCtD
Varenicline—Somnolence—Epirubicin—bone cancer	0.000872	0.000872	CcSEcCtD
Varenicline—Anorexia—Doxorubicin—bone cancer	0.000865	0.000865	CcSEcCtD
Varenicline—Feeling abnormal—Methotrexate—bone cancer	0.000864	0.000864	CcSEcCtD
Varenicline—Dyspepsia—Epirubicin—bone cancer	0.000864	0.000864	CcSEcCtD
Varenicline—Gastrointestinal pain—Methotrexate—bone cancer	0.000857	0.000857	CcSEcCtD
Varenicline—Decreased appetite—Epirubicin—bone cancer	0.000853	0.000853	CcSEcCtD
Varenicline—Hypotension—Doxorubicin—bone cancer	0.000848	0.000848	CcSEcCtD
Varenicline—Gastrointestinal disorder—Epirubicin—bone cancer	0.000847	0.000847	CcSEcCtD
Varenicline—Fatigue—Epirubicin—bone cancer	0.000846	0.000846	CcSEcCtD
Varenicline—Pain—Epirubicin—bone cancer	0.000839	0.000839	CcSEcCtD
Varenicline—Constipation—Epirubicin—bone cancer	0.000839	0.000839	CcSEcCtD
Varenicline—Urticaria—Methotrexate—bone cancer	0.000833	0.000833	CcSEcCtD
Varenicline—Body temperature increased—Methotrexate—bone cancer	0.000829	0.000829	CcSEcCtD
Varenicline—Abdominal pain—Methotrexate—bone cancer	0.000829	0.000829	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000827	0.000827	CcSEcCtD
Varenicline—Insomnia—Doxorubicin—bone cancer	0.000821	0.000821	CcSEcCtD
Varenicline—Dyspnoea—Doxorubicin—bone cancer	0.000809	0.000809	CcSEcCtD
Varenicline—Feeling abnormal—Epirubicin—bone cancer	0.000809	0.000809	CcSEcCtD
Varenicline—Somnolence—Doxorubicin—bone cancer	0.000807	0.000807	CcSEcCtD
Varenicline—Gastrointestinal pain—Epirubicin—bone cancer	0.000802	0.000802	CcSEcCtD
Varenicline—Dyspepsia—Doxorubicin—bone cancer	0.000799	0.000799	CcSEcCtD
Varenicline—Decreased appetite—Doxorubicin—bone cancer	0.000789	0.000789	CcSEcCtD
Varenicline—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000784	0.000784	CcSEcCtD
Varenicline—Fatigue—Doxorubicin—bone cancer	0.000783	0.000783	CcSEcCtD
Varenicline—Urticaria—Epirubicin—bone cancer	0.000779	0.000779	CcSEcCtD
Varenicline—Pain—Doxorubicin—bone cancer	0.000776	0.000776	CcSEcCtD
Varenicline—Constipation—Doxorubicin—bone cancer	0.000776	0.000776	CcSEcCtD
Varenicline—Body temperature increased—Epirubicin—bone cancer	0.000776	0.000776	CcSEcCtD
Varenicline—Abdominal pain—Epirubicin—bone cancer	0.000776	0.000776	CcSEcCtD
Varenicline—Hypersensitivity—Methotrexate—bone cancer	0.000772	0.000772	CcSEcCtD
Varenicline—Asthenia—Methotrexate—bone cancer	0.000752	0.000752	CcSEcCtD
Varenicline—Feeling abnormal—Doxorubicin—bone cancer	0.000748	0.000748	CcSEcCtD
Varenicline—Gastrointestinal pain—Doxorubicin—bone cancer	0.000742	0.000742	CcSEcCtD
Varenicline—Pruritus—Methotrexate—bone cancer	0.000742	0.000742	CcSEcCtD
Varenicline—Hypersensitivity—Epirubicin—bone cancer	0.000723	0.000723	CcSEcCtD
Varenicline—Urticaria—Doxorubicin—bone cancer	0.000721	0.000721	CcSEcCtD
Varenicline—Abdominal pain—Doxorubicin—bone cancer	0.000718	0.000718	CcSEcCtD
Varenicline—Body temperature increased—Doxorubicin—bone cancer	0.000718	0.000718	CcSEcCtD
Varenicline—Diarrhoea—Methotrexate—bone cancer	0.000717	0.000717	CcSEcCtD
Varenicline—Asthenia—Epirubicin—bone cancer	0.000704	0.000704	CcSEcCtD
Varenicline—Pruritus—Epirubicin—bone cancer	0.000694	0.000694	CcSEcCtD
Varenicline—Dizziness—Methotrexate—bone cancer	0.000693	0.000693	CcSEcCtD
Varenicline—Diarrhoea—Epirubicin—bone cancer	0.000671	0.000671	CcSEcCtD
Varenicline—Hypersensitivity—Doxorubicin—bone cancer	0.000669	0.000669	CcSEcCtD
Varenicline—Vomiting—Methotrexate—bone cancer	0.000667	0.000667	CcSEcCtD
Varenicline—Rash—Methotrexate—bone cancer	0.000661	0.000661	CcSEcCtD
Varenicline—Dermatitis—Methotrexate—bone cancer	0.00066	0.00066	CcSEcCtD
Varenicline—Headache—Methotrexate—bone cancer	0.000657	0.000657	CcSEcCtD
Varenicline—Asthenia—Doxorubicin—bone cancer	0.000651	0.000651	CcSEcCtD
Varenicline—Dizziness—Epirubicin—bone cancer	0.000649	0.000649	CcSEcCtD
Varenicline—Pruritus—Doxorubicin—bone cancer	0.000642	0.000642	CcSEcCtD
Varenicline—Vomiting—Epirubicin—bone cancer	0.000624	0.000624	CcSEcCtD
Varenicline—Nausea—Methotrexate—bone cancer	0.000623	0.000623	CcSEcCtD
Varenicline—Diarrhoea—Doxorubicin—bone cancer	0.000621	0.000621	CcSEcCtD
Varenicline—Rash—Epirubicin—bone cancer	0.000619	0.000619	CcSEcCtD
Varenicline—Dermatitis—Epirubicin—bone cancer	0.000618	0.000618	CcSEcCtD
Varenicline—Headache—Epirubicin—bone cancer	0.000615	0.000615	CcSEcCtD
Varenicline—Dizziness—Doxorubicin—bone cancer	0.0006	0.0006	CcSEcCtD
Varenicline—Nausea—Epirubicin—bone cancer	0.000583	0.000583	CcSEcCtD
Varenicline—Vomiting—Doxorubicin—bone cancer	0.000577	0.000577	CcSEcCtD
Varenicline—Rash—Doxorubicin—bone cancer	0.000572	0.000572	CcSEcCtD
Varenicline—Dermatitis—Doxorubicin—bone cancer	0.000572	0.000572	CcSEcCtD
Varenicline—Headache—Doxorubicin—bone cancer	0.000569	0.000569	CcSEcCtD
Varenicline—Nausea—Doxorubicin—bone cancer	0.000539	0.000539	CcSEcCtD
